Bathing Additives in Pediatric Atopic Dermatitis
NCT02582788 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2018-08-31
Summary
The current clinical guidelines for management of atopic dermatitis now recommend bleach baths. This requires simply the addition of regular household bleach to twice-weekly baths. At the Mayo Clinic, dilute acetic acid (vinegar) has been recommended for decades in wet wraps to treat patients hospitalized for their atopic dermatitis. However, this practice has not been widely adopted in the pediatric dermatology community. Will the use of dilute acetic acid (vinegar) in twice weekly baths help manage atopic dermatitis in pediatric patients as well as, or better than, the current accepted guidelines?
Conditions
- Dermatitis, Atopic
Interventions
- OTHER
-
Bathing Additive
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Megha Tollefson, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2018-04-30
- Completion
- 2018-04-30
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
NCT02594969 ·Status: COMPLETED ·Phase: NA
-
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis
NCT03397979 ·Status: COMPLETED ·Phase: NA
-
The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis
NCT00179959 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
NCT06397781 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
NCT06488742 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03864627 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
NCT01602341 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin D in Egyptian Children With Atopic Dermatitis
NCT04468711 ·Status: COMPLETED ·Phase: PHASE3
-
Atopic Dermatitis in Atopy Predisposed Infants
NCT02906475 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis
NCT01301508 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
NCT02908698 ·Status: TERMINATED ·Phase: NA
-
Topical Steroid Formulation and Wet Wraps
NCT02680301 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
NCT02748993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.
NCT03052348 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
NCT03461302 ·Status: UNKNOWN ·Phase: PHASE4
-
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
NCT02062073 ·Status: COMPLETED ·Phase: PHASE1
-
Moisturizer to Prevent Atopic Dermatitis
NCT03808532 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
NCT02118792 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Treatments on Atopic Dermatitis
NCT01631617 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis
NCT02583022 ·Status: COMPLETED ·Phase: PHASE2
-
Barrier Enhancement for Eczema Prevention
NCT04680520 ·Status: COMPLETED ·Phase: NA
-
A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children
NCT04740892 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer
NCT03719742 ·Status: COMPLETED ·Phase: NA
-
Hydrocolloid Dressings in Diaper Dermatitis
NCT07186907 ·Status: COMPLETED ·Phase: NA
-
An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis
NCT02655679 ·Status: COMPLETED ·Phase: PHASE1/PHASE2